SURF - Surface Oncology Inc
IEX Last Trade
0.9551
-0.031 -3.193%
Share volume: 305,982
Last Updated: Tue 08 Aug 2023 09:59:31 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.99
-0.03
-3.10%
Summary score
10%
Profitability
0%
Dept financing
12%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-2.85%
Return on assets
-4.46%
Return on sales
-5993.1%
Return on invested capital
-29.74%
Total debt ratio
56.04%
Debt ratio change over timeo
-0.98%
Current Ratio
6.77%
Quick Ratio
0%
Cash Position Ratio
2.74%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-6.27%
Return on assets
-1.72%
Return on sales
0%
Return on invested capital
-110.06%
Total debt ratio
45.11%
Debt ratio change over timeo
-0.99%
Current Ratio
6.84%
Quick Ratio
0%
Cash Position Ratio
4.66%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.33%
Return on assets
-9.92%
Return on sales
0%
Return on invested capital
-67.05%
Total debt ratio
40.51%
Debt ratio change over time
-0.56%
Current Ratio
7.94%
Quick Ratio
0%
Cash Position Ratio
7.34%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-91.76%
Return on assets
-94.06%
Return on sales
14183.02%
Return on invested capital
-60.38%
Total debt ratio
-98.18%
Debt ratio change over time
-0.98%
Current Ratio
-0.28%
Quick Ratio
0%
Cash Position Ratio
-0.11%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SURF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -2.85% | -3.65% | 12.3% | 6.42% |
| Return on assets | -4.46% | 3.5% | 3.6% | 5.35% |
| Return on sales | -5993.1% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | -29.74% | 4.99% | 7.81% | 13.62% |
| Profitability | 0% | 44% | 81% | 83% |
| Total debt ratio | 56.04% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.98% | 224.03% | 6.03% | 1.46% |
| Dept financing | 14% | 50% | 19% | 8% |
| Current Ratio | 6.84% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.66% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 22% | 44% | 49% |
| Short-term ratios | SURF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.27% | -16.17% | 18.05% | 7.63% |
| Return on assets | -1.72% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | -110.06% | 6.54% | 5.97% | 19.39% |
| Profitability | 0% | 43% | 75% | 85% |
| Total debt ratio | 45.11% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.99% | 851.68% | 10.97% | 0.58% |
| Dept financing | 11% | 50% | 21% | 8% |
| Current Ratio | 6.84% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.66% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 32% | 24% | 45% |